Petros Tsantoulis

3.3k total citations
56 papers, 1.0k citations indexed

About

Petros Tsantoulis is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Petros Tsantoulis has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Petros Tsantoulis's work include Cancer Genomics and Diagnostics (7 papers), Genetic factors in colorectal cancer (7 papers) and Cancer-related Molecular Pathways (6 papers). Petros Tsantoulis is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Genetic factors in colorectal cancer (7 papers) and Cancer-related Molecular Pathways (6 papers). Petros Tsantoulis collaborates with scholars based in Switzerland, United States and Greece. Petros Tsantoulis's co-authors include Vassilis G. Gorgoulis, N G Kastrinakis, George Laskaris, Athanassios Kotsinas, Christos Kittas, Alfredo Addeo, Konstantinos Evangelou, Alex Friedlaender, Kostas Evangelou and Maria Sideridou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Reviews Molecular Cell Biology.

In The Last Decade

Petros Tsantoulis

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petros Tsantoulis Switzerland 17 635 398 209 148 126 56 1.0k
Mariko Mihara Japan 21 745 1.2× 674 1.7× 230 1.1× 203 1.4× 64 0.5× 38 1.3k
Chad A. Glazer United States 18 976 1.5× 293 0.7× 502 2.4× 127 0.9× 97 0.8× 21 1.3k
Jan Åkervall Sweden 20 564 0.9× 418 1.1× 224 1.1× 164 1.1× 216 1.7× 44 1.1k
Hening Ren United States 15 621 1.0× 257 0.6× 227 1.1× 113 0.8× 31 0.2× 21 976
Semra Demokan Türkiye 16 684 1.1× 203 0.5× 271 1.3× 74 0.5× 64 0.5× 33 873
Vali Papadimitrakopoulou United States 16 501 0.8× 558 1.4× 185 0.9× 257 1.7× 51 0.4× 21 1.3k
Petra Kristel Netherlands 14 760 1.2× 643 1.6× 271 1.3× 117 0.8× 154 1.2× 19 1.2k
Tserenchunt Gansukh Germany 14 278 0.4× 313 0.8× 125 0.6× 88 0.6× 71 0.6× 17 729
Amy Rose United States 15 780 1.2× 363 0.9× 528 2.5× 171 1.2× 33 0.3× 47 1.4k
Weihua Liang China 19 594 0.9× 230 0.6× 321 1.5× 164 1.1× 33 0.3× 54 893

Countries citing papers authored by Petros Tsantoulis

Since Specialization
Citations

This map shows the geographic impact of Petros Tsantoulis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petros Tsantoulis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petros Tsantoulis more than expected).

Fields of papers citing papers by Petros Tsantoulis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petros Tsantoulis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petros Tsantoulis. The network helps show where Petros Tsantoulis may publish in the future.

Co-authorship network of co-authors of Petros Tsantoulis

This figure shows the co-authorship network connecting the top 25 collaborators of Petros Tsantoulis. A scholar is included among the top collaborators of Petros Tsantoulis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petros Tsantoulis. Petros Tsantoulis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Borgeaud, Maxime, et al.. (2025). Dormant Tumor Cells: Current Opportunities and Challenges in Clinical Practice. SHILAP Revista de lepidopterología. 5(1). 3–3. 2 indexed citations
3.
Wang, Yiran, Petros Tsantoulis, Olivier Michielin, et al.. (2025). Decoding the interactions and functions of non-coding RNA with artificial intelligence. Nature Reviews Molecular Cell Biology. 26(10). 797–818. 1 indexed citations
4.
Chee, Lynette, Ann S. J. Yeoh, Matan Thangavelu Thangavelu, et al.. (2025). Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype. Cell Death and Disease. 16(1). 529–529. 2 indexed citations
5.
Charrier, Mélinda, et al.. (2025). Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with Chemotherapy. Cancers. 17(14). 2370–2370. 1 indexed citations
6.
Wirapati, Pratyaksha, Yourae Hong, Leslie Samuel, et al.. (2024). Exploratory biomarker analysis for predicting treatment effects of aflibercept in the VELOUR trial.. Journal of Clinical Oncology. 42(16_suppl). 3592–3592.
7.
Tsantoulis, Petros, et al.. (2024). A single-sample gene-expression classifier for the intrinsic consensus molecular subtypes in colorectal cancer.. Journal of Clinical Oncology. 42(16_suppl). e15587–e15587.
8.
Vito, Claudio De, et al.. (2024). EP.12F.03 Trametinib in the Treatment of Patients with Metastatic Lung Adenocarcinoma Harboring NF1 Mutation. Journal of Thoracic Oncology. 19(10). S655–S656.
9.
Pradervand, Sylvain, Rita Achermann, Simon Haefliger, et al.. (2024). Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers. SHILAP Revista de lepidopterología. 6. 100075–100075. 1 indexed citations
10.
Borgeaud, Maxime, et al.. (2023). Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers – Current Landscape. Praxis. 112(3). 149–155. 1 indexed citations
11.
Missiaglia, Edoardo, Olivier Michielin, Petros Tsantoulis, et al.. (2023). Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. International Journal of Molecular Sciences. 24(5). 4520–4520. 7 indexed citations
12.
Chaskar, Prasad, Rachel Marcone, Stephan Ryser, et al.. (2023). Clonal expansion of intra‐epithelial T cells in breast cancer revealed by spatial transcriptomics. International Journal of Cancer. 153(9). 1568–1578. 8 indexed citations
13.
White, Mark, Petros Tsantoulis, Tamsin R.M. Lannagan, et al.. (2022). 26P NOTCH1 driven metastasis in BRAF mutated colorectal cancer. Annals of Oncology. 33. S554–S554.
14.
Britschgi, Christian, Sylvain Pradervand, Rita Achermann, et al.. (2022). Structure-based prediction of BRAF mutation classes using machine-learning approaches. Scientific Reports. 12(1). 12528–12528. 7 indexed citations
15.
Özdemir, Berna C., Pierre Bohanes, Bettina Bisig, et al.. (2019). Deep Response to Anti-PD-1 Therapy of Metastatic Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor With CD274/PD-L1 Amplification. JCO Precision Oncology. 3(3). 1–6. 17 indexed citations
16.
Ballestrero, Alberto, Davide Bedognetti, Domenico Ferraioli, et al.. (2017). Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer. Journal of Translational Medicine. 15(1). 199–199. 28 indexed citations
17.
Tsantoulis, Petros, et al.. (2017). [Follow-up of the long-term cancer survivor].. PubMed. 13(563). 1044–1048. 2 indexed citations
18.
Olivier, Timothée, Pierre O. Chappuis, & Petros Tsantoulis. (2016). [Bioinformatics: a key role in oncology].. PubMed. 12(519). 978–81. 1 indexed citations
19.
Evangelou, Kostas, Petros Tsantoulis, Michalis Liontos, et al.. (2007). Gene amplification is a relatively frequent event leading to ZBTB7A ( Pokemon ) overexpression in non‐small cell lung cancer. The Journal of Pathology. 213(3). 294–302. 56 indexed citations
20.
Tsantoulis, Petros, Mirsini Kouloukoussa, Konstantinos Evangelou, et al.. (2006). Centrosome abnormalities are frequently observed in non‐small‐cell lung cancer and are associated with aneuploidy and cyclin E overexpression. The Journal of Pathology. 209(4). 512–521. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026